TipRanks
IDEAYA Biosciences (DE:30J)
FRANKFURT:30J
Germany Market
30J
IDEAYA Biosciences
RESEARCH TOOLSreports

IDEAYA Biosciences (30J) Stock News & Sentiment

4 Followers
IDEAYA Biosciences: Buy Rating Reiterated as Competitive Landscape Improves; $58 Price Target Maintained
Premium
Ratings
IDEAYA Biosciences: Buy Rating Reiterated as Competitive Landscape Improves; $58 Price Target Maintained
14d ago
IDYA
IDEAYA Biosciences: Strategic Oncology Collaborations and Strong Cash Position Support Buy Rating with Unchanged $58 Price Target
Premium
Ratings
IDEAYA Biosciences: Strategic Oncology Collaborations and Strong Cash Position Support Buy Rating with Unchanged $58 Price Target
2M ago
IDYA
IDEAYA Biosciences: Buy Rating Reiterated as Precision Oncology Pipeline Advances and $62 Price Target Maintained
Premium
Ratings
IDEAYA Biosciences: Buy Rating Reiterated as Precision Oncology Pipeline Advances and $62 Price Target Maintained
3M ago
IDYA
IDEAYA Biosciences Shareholders Back Leadership, Governance Changes
Premium
Company Announcements
IDEAYA Biosciences Shareholders Back Leadership, Governance Changes
4M ago
8K
IDYA
Ideaya Advances IDE034 Into First-in-Human Trial for Advanced Solid Tumors
Premium
Company Announcements
Ideaya Advances IDE034 Into First-in-Human Trial for Advanced Solid Tumors
4M ago
IDYA
IDEAYA Biosciences Raises $324 Million in Equity Offering
Premium
Company Announcements
IDEAYA Biosciences Raises $324 Million in Equity Offering
4M ago
8K
IDYA
Analyst Reiterates Buy on IDEAYA, Citing Strong Oncology Pipeline and Partnerships with Unchanged $62 Price Target
Premium
Ratings
Analyst Reiterates Buy on IDEAYA, Citing Strong Oncology Pipeline and Partnerships with Unchanged $62 Price Target
4M ago
IDYA
More DE:30J News >

30J News on the Web

IDEAYA Biosciences: Buy Rating Reiterated as Competitive Landscape Improves; $58 Price Target Maintained
TipRanks News
Bullish
Can IDEAYA Biosciences (IDYA) Turn Uncharted Oncology Territory Into Commercial Gold?
Insider Monkey
Neutral
IDEAYA Biosciences Sinks As Rally Unravels Fast
TipRanks News
Neutral
IDEAYA Biosciences Plunges After Price Target Cut
TipRanks News
Neutral
Logos Global Management LP Adds Longeveron Inc (LGVN) Shares -- Stock Looks 118% Overvalued on ...
GuruFocus News
Neutral
IDEAYA Biosciences, Inc. at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
IDEAYA Biosciences, Inc. at Citi Biopharma Back to School Summit Transcript
GuruFocus News
Neutral
LifeSci Capital Sticks to Its Buy Rating for IDEAYA Biosciences (IDYA)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average4 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:30J’s Media Buzz Sentiment?
Currently, no data Available
What is DE:30J’s weekly average amount of articles?
In an average week, 4 articles about DE:30J are published.
    What is DE:30J’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    AMGNAmgen
    GKOSGlaukos
    OVIDOvid Therapeutics
    ABTAbbott Laboratories
    IQVIQVIA Holdings
    Showing the stocks with the most bullish news sentiment over the past week